Stocks · Health care · Pharmaceutical Preparations

Aktis Oncology, Inc.

AKTS
United States Fiscal year ends December CIK 0002035832
$18.15 +2.31% Close, 9 Oct 2026
Price $18.15 +2.72% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 9 Jan 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for AKTS. They arrive with the nightly refresh; a company joins the screen the first time one is.